185 related articles for article (PubMed ID: 6439588)
1. myo-Inositol and sorbitol in erythrocytes from diabetic patients before and after sorbinil treatment.
Popp-Snijders C; Lomecky-Janousek MZ; Schouten JA; van der Veen EA
Diabetologia; 1984 Nov; 27(5):514-6. PubMed ID: 6439588
[TBL] [Abstract][Full Text] [Related]
2. Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition.
Gillon KR; Hawthorne JN; Tomlinson DR
Diabetologia; 1983 Oct; 25(4):365-71. PubMed ID: 6416913
[TBL] [Abstract][Full Text] [Related]
3. Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomic ganglia of streptozocin-induced diabetic rats.
Schmidt RE; Plurad SB; Sherman WR; Williamson JR; Tilton RG
Diabetes; 1989 May; 38(5):569-79. PubMed ID: 2497038
[TBL] [Abstract][Full Text] [Related]
4. Treatment with aldose reductase inhibitor or with myo-inositol arrests deterioration of the electroretinogram of diabetic rats.
MacGregor LC; Matschinsky FM
J Clin Invest; 1985 Aug; 76(2):887-9. PubMed ID: 3928685
[TBL] [Abstract][Full Text] [Related]
5. The effect of aldose reductase inhibition on erythrocyte polyols and galactitol accumulation in diabetic patients.
Airey CM; Price DE; Kemp JV; Perkins CM; Wales JK
Diabet Med; 1989 Dec; 6(9):804-8. PubMed ID: 2533041
[TBL] [Abstract][Full Text] [Related]
6. Effects of sorbinil treatment on erythrocytes and platelets of persons with diabetes.
Martyn CN; Matthews DM; Popp-Snijders C; Tucker J; Ewing DJ; Clarke BF
Diabetes Care; 1986; 9(1):36-9. PubMed ID: 3948646
[TBL] [Abstract][Full Text] [Related]
7. Increased nerve polyol levels in experimental diabetes and their reversal by Sorbinil.
Whiting PH; Ross IS
Br J Exp Pathol; 1988 Oct; 69(5):697-702. PubMed ID: 3143396
[TBL] [Abstract][Full Text] [Related]
8. Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil.
Beyer-Mears A; Ku L; Cohen MP
Diabetes; 1984 Jun; 33(6):604-7. PubMed ID: 6427041
[TBL] [Abstract][Full Text] [Related]
9. The effects of aldose reductase inhibition on nerve sorbitol and myoinositol concentrations in diabetic and galactosemic rats.
Yue DK; Hanwell MA; Satchell PM; Handelsman DJ; Turtle JR
Metabolism; 1984 Dec; 33(12):1119-22. PubMed ID: 6438438
[TBL] [Abstract][Full Text] [Related]
10. Na+-K+-ATPase pumping activity is not directly linked to myo-inositol levels after sorbinil treatment in lenses of diabetic rats.
Yeh LA; Rafford CE; Goddu KJ; Ashton MA; Beyer TA; Hutson NJ
Diabetes; 1987 Dec; 36(12):1414-9. PubMed ID: 2824260
[TBL] [Abstract][Full Text] [Related]
11. The penetration of Sorbinil, an aldose reductase inhibitor, into lens, aqueous humour and erythrocytes of patients undergoing cataract extraction.
Crabbe MJ; Petchey M; Burgess SE; Cheng H
Exp Eye Res; 1985 Jan; 40(1):95-9. PubMed ID: 3920064
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in the therapy of diabetic peripheral neuropathy by means of an aldose reductase inhibitor.
Greene DA; Lattimer SA
Am J Med; 1985 Nov; 79(5A):13-7. PubMed ID: 3000175
[TBL] [Abstract][Full Text] [Related]
13. Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy.
Dyck PJ; Zimmerman BR; Vilen TH; Minnerath SR; Karnes JL; Yao JK; Poduslo JF
N Engl J Med; 1988 Sep; 319(9):542-8. PubMed ID: 3136330
[TBL] [Abstract][Full Text] [Related]
14. Six-month treatment with sorbinil in asymptomatic diabetic neuropathy. Failure to improve abnormal nerve function.
Martyn CN; Reid W; Young RJ; Ewing DJ; Clarke BF
Diabetes; 1987 Sep; 36(9):987-90. PubMed ID: 3111914
[TBL] [Abstract][Full Text] [Related]
15. Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor.
Beyer-Mears A; Cruz E
Diabetes; 1985 Jan; 34(1):15-21. PubMed ID: 3917257
[TBL] [Abstract][Full Text] [Related]
16. An aldose reductase inhibitor but not myo-inositol blocks enhanced polyphosphoinositide turnover in peripheral nerve from diabetic rats.
Berti-Mattera L; Day N; Peterson RG; Eichberg J
Metabolism; 1996 Mar; 45(3):320-7. PubMed ID: 8606638
[TBL] [Abstract][Full Text] [Related]
17. Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil.
Tomlinson DR; Moriarty RJ; Mayer JH
Diabetes; 1984 May; 33(5):470-6. PubMed ID: 6202576
[TBL] [Abstract][Full Text] [Related]
18. [Diabetic neuropathy: treatment trial with an aldose reductase inhibitor (Sorbinil)].
Christensen JE; Larsen AB; Gregersen G
Ugeskr Laeger; 1987 Nov; 149(46):3111-4. PubMed ID: 3127975
[No Abstract] [Full Text] [Related]
19. Aldose reductase, glomerular metabolism, and diabetic nephropathy.
Cohen MP
Metabolism; 1986 Apr; 35(4 Suppl 1):55-9. PubMed ID: 3007926
[TBL] [Abstract][Full Text] [Related]
20. The effect of an aldose reductase inhibitor (Sorbinil) on diabetic neuropathy and neural function of the retina: a double-blind study.
Christensen JE; Varnek L; Gregersen G
Acta Neurol Scand; 1985 Feb; 71(2):164-7. PubMed ID: 3920861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]